Content about Diplomatic Relations

November 2, 2012
Meningitis outbreak linked to compounding pharmacy spawns new proposed legislation

Rep. Edward Markey, D-Mass., on Thursday announced plans to introduce legislation that would strengthen federal regulations of compounding pharmacies.

ALEXANDRIA, Va. — Rep. Edward Markey, D-Mass., on Thursday announced plans to introduce legislation that would strengthen federal regulations of compounding pharmacies. The legislation is borne out of the recent meningitis outbreak linked to the New England Compounding Center, which is located in Markey's district, that has drawn much criticism on how regulators oversee compounding pharmacies.

October 19, 2011
NACDS to Senate: Prevent move to 'personal importation' of prescription drugs

An amendment to the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill that would prohibit the FDA from preventing an individual not in the business of importing a prescription drug from importing prescription drugs from Canada, has sparked concern with the National Association of Chain Drug Stores.

ALEXANDRIA, Va. — An amendment to the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill that would prohibit the FDA from preventing an individual not in the business of importing a prescription drug from importing prescription drugs from Canada, has sparked concern with the National Association of Chain Drug Stores.

January 21, 2011
Forest Labs announces phase-3 trial results for depression drug

A drug for major depressive disorder worked better than placebo, according to results of a late-stage clinical trial announced Thursday.

NEW YORK — A drug for major depressive disorder worked better than placebo, according to results of a late-stage clinical trial announced Thursday.

U.S. drug maker Forest Labs and French drug maker Pierre Fabre Medicament said that while the overall difference between patients treated with levomilnacipran and those treated with the placebo was not statistically significant, the drug consistently demonstrated improvement relative to the placebo over the course of the phase-3 trial.